Aerie Pharmaceuticals, Inc. Selling, General and Administrative Expense
Aerie Pharmaceuticals, Inc. reported Selling, General and Administrative Expense of $33.88 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-11-04
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2022-09-30 was $33.88M, a 2.24% decline year-over-year.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $28.15M, a 18.51% decline year-over-year.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $31.52M, a 3.29% decline year-over-year.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $36.01M, a 2.84% increase year-over-year.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2021 was $137.81M, a 0.45% increase from fiscal 2020.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2020 was $137.18M, a 0.88% decline from fiscal 2019.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2019 was $138.40M, a 14.75% increase from fiscal 2018.
- Aerie Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2018 was $120.61M, a 111.96% increase from fiscal 2017.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $33.88M 10-Q · filed 2022-11-04 | $62.03M derived: sum of 2 quarters · filed 2022-11-04 | $93.55M 10-Q · filed 2022-11-04 | $129.56M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2022-06-30 | $28.15M 10-Q · filed 2022-08-05 | $59.67M 10-Q · filed 2022-08-05 | $95.68M derived: sum of 3 quarters · filed 2022-08-05 | $130.34M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2022-03-31 | $31.52M 10-Q · filed 2022-05-06 | $67.53M derived: sum of 2 quarters · filed 2022-05-06 | $102.19M derived: sum of 3 quarters · filed 2022-11-04 | $136.73M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-12-31 | $36.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $70.67M derived: sum of 2 quarters · filed 2022-11-04 | $105.21M derived: sum of 3 quarters · filed 2022-11-04 | $137.81M 10-K · filed 2022-02-25 | ||||
| 2021-09-30 | $34.66M 10-Q · filed 2022-11-04 | $69.20M derived: sum of 2 quarters · filed 2022-11-04 | $101.80M 10-Q · filed 2022-11-04 | $136.81M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | $34.54M 10-Q · filed 2022-08-05 | $67.14M 10-Q · filed 2022-08-05 | $102.16M derived: sum of 3 quarters · filed 2022-08-05 | $134.19M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $32.60M 10-Q · filed 2022-05-06 | $67.61M derived: sum of 2 quarters · filed 2022-05-06 | $99.64M derived: sum of 3 quarters · filed 2022-05-06 | $132.88M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $35.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $67.05M derived: sum of 2 quarters · filed 2022-02-25 | $100.28M derived: sum of 3 quarters · filed 2022-02-25 | $137.18M 10-K · filed 2022-02-25 | ||||
| 2020-09-30 | $32.03M 10-Q · filed 2021-11-05 | $65.27M derived: sum of 2 quarters · filed 2021-11-05 | $102.17M 10-Q · filed 2021-11-05 | $137.63M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $33.24M 10-Q · filed 2021-08-05 | $70.14M 10-Q · filed 2021-08-05 | $105.61M derived: sum of 3 quarters · filed 2022-02-25 | $137.78M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $36.90M 10-Q · filed 2021-05-06 | $72.37M derived: sum of 2 quarters · filed 2022-02-25 | $104.54M derived: sum of 3 quarters · filed 2022-02-25 | $139.02M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $35.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $67.64M derived: sum of 2 quarters · filed 2022-02-25 | $102.12M derived: sum of 3 quarters · filed 2022-02-25 | $138.40M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $32.17M 10-Q · filed 2020-11-06 | $66.65M derived: sum of 2 quarters · filed 2020-11-06 | $102.94M 10-Q · filed 2020-11-06 | $134.82M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $34.48M 10-Q · filed 2020-08-07 | $70.76M 10-Q · filed 2020-08-07 | $102.65M derived: sum of 3 quarters · filed 2021-02-26 | $135.34M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $36.28M 10-Q · filed 2020-05-07 | $68.17M derived: sum of 2 quarters · filed 2021-02-26 | $100.85M derived: sum of 3 quarters · filed 2021-02-26 | $133.97M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $31.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $64.57M derived: sum of 2 quarters · filed 2021-02-26 | $97.68M derived: sum of 3 quarters · filed 2021-02-26 | $120.61M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $32.69M 10-Q · filed 2019-11-07 | $39.93M 10-Q · filed 2018-11-07 | $65.80M derived: sum of 2 quarters · filed 2019-11-07 | $88.73M 10-Q · filed 2019-11-07 | $107.65M 10-Q · filed 2018-11-07 | $94.23M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $33.11M 10-Q · filed 2019-08-08 | $39.89M 10-Q · filed 2018-08-09 | $56.04M 10-Q · filed 2019-08-08 | $67.71M 10-Q · filed 2018-08-09 | $61.55M derived: sum of 3 quarters · filed 2020-02-24 | $81.32M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $22.93M 10-Q · filed 2019-05-08 | $27.82M 10-Q · filed 2018-05-09 | $28.43M derived: sum of 2 quarters · filed 2020-02-24 | $48.21M derived: sum of 3 quarters · filed 2020-02-24 | $65.36M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $25.28M derived: sum of 2 quarters · filed 2020-02-24 | $42.43M derived: sum of 3 quarters · filed 2020-02-24 | $56.91M 10-K · filed 2020-02-24 | $73.61M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $19.77M 10-Q · filed 2018-11-07 | $36.93M derived: sum of 2 quarters · filed 2018-11-07 | $51.40M 10-Q · filed 2018-11-07 | $56.29M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $17.15M 10-Q · filed 2018-08-09 | $31.63M 10-Q · filed 2018-08-09 | $36.52M derived: sum of 3 quarters · filed 2019-03-01 | $47.15M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $14.47M 10-Q · filed 2018-05-09 | $19.37M derived: sum of 2 quarters · filed 2019-03-01 | $29.99M derived: sum of 3 quarters · filed 2019-03-01 | $39.38M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $15.52M derived: sum of 2 quarters · filed 2019-03-01 | $24.91M derived: sum of 3 quarters · filed 2019-03-01 | $34.71M 10-K · filed 2019-03-01 | $44.48M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $10.63M 10-Q · filed 2017-11-09 | $20.01M derived: sum of 2 quarters · filed 2017-11-09 | $29.81M 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $9.39M 10-Q · filed 2017-08-03 | $19.19M 10-Q · filed 2017-08-03 | ||||||
| 2016-03-31 | $9.80M 10-Q · filed 2017-05-03 | |||||||
| 2015-12-31 | $30.64M 10-K · filed 2018-03-01 |